Correlation Between Arrowhead Pharmaceuticals and Moderna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharmaceuticals and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharmaceuticals and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arrowhead Pharmaceuticals and Moderna, you can compare the effects of market volatilities on Arrowhead Pharmaceuticals and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharmaceuticals with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharmaceuticals and Moderna.

Diversification Opportunities for Arrowhead Pharmaceuticals and Moderna

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Arrowhead and Moderna is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharmaceuticals and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and Arrowhead Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharmaceuticals are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of Arrowhead Pharmaceuticals i.e., Arrowhead Pharmaceuticals and Moderna go up and down completely randomly.

Pair Corralation between Arrowhead Pharmaceuticals and Moderna

Assuming the 90 days trading horizon Arrowhead Pharmaceuticals is expected to generate 1.17 times more return on investment than Moderna. However, Arrowhead Pharmaceuticals is 1.17 times more volatile than Moderna. It trades about 0.0 of its potential returns per unit of risk. Moderna is currently generating about -0.06 per unit of risk. If you would invest  3,512  in Arrowhead Pharmaceuticals on September 19, 2024 and sell it today you would lose (1,402) from holding Arrowhead Pharmaceuticals or give up 39.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

Arrowhead Pharmaceuticals  vs.  Moderna

 Performance 
       Timeline  
Arrowhead Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Arrowhead Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Moderna 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Arrowhead Pharmaceuticals and Moderna Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arrowhead Pharmaceuticals and Moderna

The main advantage of trading using opposite Arrowhead Pharmaceuticals and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharmaceuticals position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.
The idea behind Arrowhead Pharmaceuticals and Moderna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets